Back
Bicara Therapeutics, Inc. 10K Form
Sell
33
BCAX
Bicara Therapeutics, Inc.
Last Price:
$19.01
Seasonality Move:
-32.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BCAX News And Ratings
See the #1 stock for the next 7 days that we like better than BCAX
BCAX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-29.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.38 |
| Price / Book: | 2.48 |
Profitability
| EPS (TTM): | -2.22960 |
|---|---|
| Net Income (TTM): | $-121.5M |
| Gross Margin: | $-56K |
| Return on Equity: | -26.44% |
| Return on Assets: | -24.8% |
Bicara Therapeutics, Inc. Earnings Forecast
Key Bicara Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 3 years have been positive in 0 years.
Bicara Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BCAX |
| Website: | bicara.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 14.14 |
| Quick Ratio: | 13.8 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BCAX Technical Analysis vs Fundamental Analysis
Sell
33
Bicara Therapeutics, Inc. (BCAX)
is a Sell
Is Bicara Therapeutics, Inc. a Buy or a Sell?
-
Bicara Therapeutics, Inc. stock is rated a SellThe current Bicara Therapeutics, Inc. [BCAX] share price is $18.20. The Score for BCAX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.